A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy

This study is currently recruiting participants.

Verified April 2013 by Janssen Research & Development, LLC

Sponsor:

Information provided by (Responsible Party):

Janssen Research & Development, LLC

ClinicalTrials.gov Identifier:

NCT01645280

First received: June 6, 2012

Last updated: April 25, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2014
Estimated Primary Completion Date:	March 2014 (Final data collection date for primary outcome measure)